These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 26267219)

  • 21. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
    Stuebner P; Horak F; Zieglmayer R; Arnáiz E; Leuratti C; Pérez I; Izquierdo I
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):37-44. PubMed ID: 16440531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
    González-Núñez V; Bachert C; Mullol J
    Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and efficacy of desloratadine for the management of allergic disease.
    Berger WE
    Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M; Yagami A; Togawa M; Saito A; Furue M
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: A 12-month, multicenter, open-label clinical trial.
    Hide M; Suzuki T; Tanaka A; Aoki H
    J Dermatol Sci; 2019 Jun; 94(3):339-345. PubMed ID: 31196788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
    Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
    Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
    Antonijoan R; Coimbra J; García-Gea C; Puntes M; Gich I; Campo C; Valiente R; Labeaga L
    Curr Med Res Opin; 2017 Jan; 33(1):129-136. PubMed ID: 27659218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
    Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
    J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Ring J; Hein R; Gauger A; Bronsky E; Miller B
    Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
    Weller K; Ardelean E; Scholz E; Martus P; Zuberbier T; Maurer M
    Acta Derm Venereol; 2013 Mar; 93(2):168-74. PubMed ID: 23053062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
    Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
    Saint-Martin F; Dumur JP; Pérez I; Izquierdo I;
    J Investig Allergol Clin Immunol; 2004; 14(1):34-40. PubMed ID: 15160440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety.
    Maiti R; Jaida J; Raghavendra BN; Goud P; Ahmed I; Palani A
    J Drugs Dermatol; 2011 Dec; 10(12):1444-50. PubMed ID: 22134570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
    Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
    J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
    Picado C
    Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desloratadine: a nonsedating antihistamine.
    Limon L; Kockler DR
    Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.